Discontinued operations - General (Details) $ in Millions |
3 Months Ended | 6 Months Ended | 18 Months Ended | ||
|---|---|---|---|---|---|
|
Apr. 02, 2024
USD ($)
|
Apr. 02, 2024
CHF (SFr)
|
Jun. 30, 2024
CHF (SFr)
|
Jun. 30, 2024
CHF (SFr)
|
Jun. 30, 2025
CHF (SFr)
|
|
| Neurosterix Pharma Sarl | |||||
| Disclosure | |||||
| Amount of committed funding received in million | $ | $ 65 | ||||
| Neurosterix US Holdings LLC | |||||
| Disclosure | |||||
| Percentage of equity interest received | 20.00% | 20.00% | |||
| Discontinued operations as disclosed below | |||||
| Disclosure | |||||
| Gross proceeds in cash received from Neurosterix Transaction | SFr | SFr 5,000,000 | SFr 5,000,000 | SFr 5,000,000 | SFr 5,000,000 | |
| Discontinued operations as disclosed below | Neurosterix US Holdings LLC | |||||
| Disclosure | |||||
| Percentage of equity interest received | 20.00% | 20.00% | |||